Find clinical trials for Multiple Myeloma in Detroit, MI
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Multiple Myeloma trials near Detroit, MI, USA:
This research study is studying a combination of study drugs as a possible treatment for relapsed and refractory Multiple Myeloma. ...
Phase 2
Ann Arbor, Michigan, United States and 5 other locations
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
This research study is studying a targeted therapy as a possible treatment for multiple myeloma.The names of the study drugs involv...
Phase 1
Detroit, Michigan, United States and 1 other location
This research study is studying a drug as a possible treatment for Monoclonal Gammopathy of Unknown Significance (MGUS) or Smoldering Multiple...
Phase 2
Detroit, Michigan, United States and 5 other locations
The purpose of this study is to evaluate the safety and preliminary efficacy of CC-92480 in combination with standard treatments.
Phase 1, Phase 2
Detroit, Michigan, United States and 48 other locations
is a Phase 1b/2, open-label, multicenter study of AZD0120, a CD19/BCMA dual CAR T-cell therapy, in adult subjects with relapsed/refractory multiple...
Phase 1, Phase 2
Detroit, Michigan, United States and 35 other locations
The purpose of this research study is to evaluate a treatment regimen called IRD which will be given to participants after their stem cell transplant...
Phase 2
Detroit, Michigan, United States and 9 other locations
versus Daratumumab, Bortezomib, Lenalidomide and Dexamethasone (DVRd) followed by Autologous Stem Cell Transplant (ASCT) in newly diagnosed multiple...
Phase 3
Detroit, Michigan, United States and 107 other locations
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spon...
Phase 1
Ann Arbor, Michigan, United States and 14 other locations
This is a post-trial access (PTA) open-label, single-arm study in Multiple Myeloma participants who continue to derive clinical ben...
Phase 4
Detroit, Michigan, United States and 33 other locations
This is a Phase I/II, modular, open-label, multicenter, dose escalation, and dose expansion/optimization study to evaluate the safety, tolerability,...
Phase 1, Phase 2
Ann Arbor, Michigan, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal